Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Maeda

Showing results (161-170 of 233) with videos related to

Pageof 24
Sort By:
Journal of Virology|January 5, 2002
A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active siteKazuhisa Yoshimura, Ryohei Kato, Mark F Kavlick, et al.
Marine Drugs|January 27, 2026
Onnamides A and B Suppress Hepatitis B Virus Transcription by Inhibiting Viral Promoter ActivityYasuhiro Hayashi, Sei Arizono, Nanami Higa, et al.
NPJ Parkinson'S Disease|May 11, 2026
Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseasesSonia S Muñoz, Frederik R Marlet, Jesper E Dreier, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 3, 2021
Identification of lysosome-targeting drugs with anti-inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancersMalene Bredahl Hansen, Maria Postol, Siri Tvingsholm, et al.
Scientific Reports|August 25, 2019
HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirusSaori C Iwase, Paola Miyazato, Hiroo Katsuya, et al.
Frontiers in Microbiology|April 5, 2021
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC ActivatorsKouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 28, 2017
Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasiaYukio Homma, Momokazu Gotoh, Akihiro Kawauchi, et al.
The EMBO Journal|November 21, 2022
Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repairMaja Radulovic, Eva Maria Wenzel, Sania Gilani, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profilesRena Nishizawa, Toshihiko Nishiyama, Katsuya Hisaichi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 16, 2024
Lipid levels correlate with neuronal and dopaminergic markers during the differentiation of SH-SY5Y cellsFrederik Ravnkilde Marlet, Sonia Sanz Muñoz, Nefeli Sotiraki, et al.
Pageof 24

Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Journal of Virology|January 5, 2002
A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active siteKazuhisa Yoshimura, Ryohei Kato, Mark F Kavlick, et al.
Marine Drugs|January 27, 2026
Onnamides A and B Suppress Hepatitis B Virus Transcription by Inhibiting Viral Promoter ActivityYasuhiro Hayashi, Sei Arizono, Nanami Higa, et al.
NPJ Parkinson'S Disease|May 11, 2026
Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseasesSonia S Muñoz, Frederik R Marlet, Jesper E Dreier, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 3, 2021
Identification of lysosome-targeting drugs with anti-inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancersMalene Bredahl Hansen, Maria Postol, Siri Tvingsholm, et al.
Scientific Reports|August 25, 2019
HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirusSaori C Iwase, Paola Miyazato, Hiroo Katsuya, et al.
Frontiers in Microbiology|April 5, 2021
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC ActivatorsKouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 28, 2017
Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasiaYukio Homma, Momokazu Gotoh, Akihiro Kawauchi, et al.
The EMBO Journal|November 21, 2022
Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repairMaja Radulovic, Eva Maria Wenzel, Sania Gilani, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profilesRena Nishizawa, Toshihiko Nishiyama, Katsuya Hisaichi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 16, 2024
Lipid levels correlate with neuronal and dopaminergic markers during the differentiation of SH-SY5Y cellsFrederik Ravnkilde Marlet, Sonia Sanz Muñoz, Nefeli Sotiraki, et al.
Pageof 24